These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2043218)

  • 1. Hypertension as a metabolic disorder--an overview.
    Smith U; Gudbjörnsdottir S; Landin K
    J Intern Med Suppl; 1991; 735():1-7. PubMed ID: 2043218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin resistance: an etiological factor in essential arterial hypertension and coronary cardiopathy].
    Vázquez Chávez C; Brito Zurita OR; Argüero Sánchez R; Lozano de los Santos H
    Gac Med Mex; 1993; 129(5):339-45. PubMed ID: 7926420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofibrinolysis and insulin-resistance.
    Juhan-Vague I; Vague P
    Diabete Metab; 1991 May; 17(1 Pt 2):96-100. PubMed ID: 1936490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?
    Yudkin JS
    Diabetes Care; 1999 Apr; 22 Suppl 3():C25-30. PubMed ID: 10189559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in hypertension--a relationship with consequences?
    Berne C
    J Intern Med Suppl; 1991; 735():65-73. PubMed ID: 2043224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The insulin resistance syndrome and fibrinolysis disorders].
    Okapcová J; Hrnciar J
    Vnitr Lek; 1997 Jun; 43(6):373-8. PubMed ID: 9601868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAI-1, obesity, insulin resistance and risk of cardiovascular events.
    Juhan-Vague I; Alessi MC
    Thromb Haemost; 1997 Jul; 78(1):656-60. PubMed ID: 9198234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
    Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
    Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.